These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
140 related articles for article (PubMed ID: 30179635)
1. Clinical and Radiographic Predictors of Great Vessel Resection or Reconstruction During Retroperitoneal Lymph Node Dissection for Testicular Cancer. Johnson SC; Smith ZL; Nottingham C; Schwen ZR; Thomas S; Fishman EK; Lee NJ; Pierorazio PM; Eggener SE Urology; 2019 Jan; 123():186-190. PubMed ID: 30179635 [TBL] [Abstract][Full Text] [Related]
2. Preoperative clinical and radiographic predictors of major vascular surgery in patients with testicular cancer undergoing post-chemotherapy residual tumor resection (PC-RPLND). Nini A; Boschheidgen M; Hiester A; Winter C; Antoch G; Schimmöller L; Albers P World J Urol; 2022 Feb; 40(2):349-354. PubMed ID: 34731264 [TBL] [Abstract][Full Text] [Related]
9. Long-term oncological outcome after post-chemotherapy retroperitoneal lymph node dissection in men with metastatic nonseminomatous germ cell tumour. Fléchon A; Tavernier E; Boyle H; Meeus P; Rivoire M; Droz JP BJU Int; 2010 Sep; 106(6):779-85. PubMed ID: 20089110 [TBL] [Abstract][Full Text] [Related]
10. [Long-term results of laparoscopic retroperitoneal lymph node dissection (RPLND) in low-stage nonseminomatous germ-cell testicular tumors (NSGCTT) performed by a senior surgeon: 1999-2003]. Pizzocaro G; Schiavo M; Solima S; Vitellaro M; Biasoni N; Nicolai N Urologia; 2010; 77 Suppl 17():50-6. PubMed ID: 21308676 [TBL] [Abstract][Full Text] [Related]
11. Robot-assisted Laparoscopic Retroperitoneal Lymph Node Dissection for Testicular Cancer: Evolution of the Technique. Stepanian S; Patel M; Porter J Eur Urol; 2016 Oct; 70(4):661-667. PubMed ID: 27068395 [TBL] [Abstract][Full Text] [Related]
12. Postchemotherapy laparoscopic retroperitoneal lymph node dissection for low-volume, stage II, nonseminomatous germ cell tumor: first 100 patients. Steiner H; Leonhartsberger N; Stoehr B; Peschel R; Pichler R Eur Urol; 2013 Jun; 63(6):1013-7. PubMed ID: 23021090 [TBL] [Abstract][Full Text] [Related]
13. Retroperitoneal lymph node dissection with concomitant IVC thrombectomy, caval wall resection, and grafting for metastatic NSGCT. Hakky T; Kim T; Rodriguez AR; Armstrong P; Mangar D; Spiess PE Int Braz J Urol; 2012; 38(1):135; discussion 136. PubMed ID: 22397783 [TBL] [Abstract][Full Text] [Related]
14. Midline Extraperitoneal Approach to Retroperitoneal Lymph Node Dissection in Testicular Cancer: Minimizing Surgical Morbidity. Syan-Bhanvadia S; Bazargani ST; Clifford TG; Cai J; Miranda G; Daneshmand S Eur Urol; 2017 Nov; 72(5):814-820. PubMed ID: 28325537 [TBL] [Abstract][Full Text] [Related]
15. [Clinical outcome of postchemotherapy retroperitoneal lymph node dissection and predicting retroperitoneal histology in advanced nonseminomatous germ cell tumours of the testis]. Li XD; Guo SJ; Chen SL; Liu ZF; Dong P; Zhang ZL; Jiang LJ; Yao K; Li YH; Han H; Qin ZK; Liu ZW; Zhou FJ Zhonghua Wai Ke Za Zhi; 2017 Aug; 55(8):603-607. PubMed ID: 28789511 [No Abstract] [Full Text] [Related]
16. Utilization of retroperitoneal lymph node dissection for testicular cancer in the United States: Results from the National Cancer Database (1998-2011). Hugen CM; Hu B; Jeldres C; Burton C; Nichols CR; Porter CR; Daneshmand S Urol Oncol; 2016 Nov; 34(11):487.e7-487.e11. PubMed ID: 27372281 [TBL] [Abstract][Full Text] [Related]